Nate Berkus in January 2024 (Evan Agostini/Invision/AP Images)
FDA says Merz's social media promotion with Nate Berkus is 'misleading'
Merz Pharmaceuticals landed in hot water last month when the FDA said a social media promotion for its Botox rival Xeomin was “false or misleading” …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
